American HealthCare Capital is pleased to exclusively present an opportunity to purchase a highly profitable Medical Billing/Revenue Cycle Management Company for laboratories and physician practices. The company currently has clients located in over fourteen states.
Through October 31st of 2023, total revenue was $2.4 million with an adjusted EBITDA was $765,000. The full year revenue run rate is $2.85 million with an adjusted EBITDA of $918,000. 2022 saw total revenue of $3.0 million and an adjusted EBITDA of $877,000. The company expects 2024 revenue to increase by 15% to approximately $3.5 million, with an adjusted EBITDA of $1.2 million. As such, the asking price for this opportunity is $4.8 million exclusive of the value of the company’s proprietary software (which can be discussed separately).
The seller would like to stay on to assist with the transition in ownership and help facilitate the future growth of the business for the next couple of years.
